Flu season ends with a whisper, not a bang.

Published Date: 14 Mar 2023

The 2022-2023 flu season is on the edge of life which has been predicted for half of January and most of February.

Read Full News

Latest News

Fulcrum Scraps Sickle Cell Drug Program After FDA Raises Cancer-risk Concerns

Fulcrum Therapeutics said on Monday it would stop developing its experimental sickle-cell disease drug ⁠after the U.S. Food and Drug Administration raised cancer-risk...

Incidental Splenomegaly: Which Findings Raise Concern?

Incidental splenomegaly detected on imaging may warrant closer evaluation because malignancy and cirrhosis risk increase with splenic size.

Early UC Intervention: Tips for Better Outcomes

Dr Adam Faye discusses best practices for early interventions in ulcerative colitis care.

Defecation Urgency in IBS Reframed as a Brain-Gut Phenomenon

Although the sensation of defecation urgency in patients with IBS appears in the gut, a recent study suggests that it’s nuanced and related to several regions of the brain.

What a Baby’s Laughter Reveals About the Developing Brain

Experts say an infant’s laughter is an important developmental marker, offering a window into brain development and a child’s emerging social world.

Fecal Transplant Curbs Alcohol Cravings

A single fecal microbiota transplantation improved alcohol abstinence and reduced relapse rates in patients with alcohol-associated cirrhosis and alcohol use disorder.

Todays Updates

Chiauranib Slows Platinum-Resistant Ovarian Cancer

The investigational drug extends progression-free survival in a phase 3 trial in patients with platinum-resistant or -refractory ovarian cancer.

Todays Updates

Chiauranib Slows Platinum-Resistant Ovarian Cancer

The investigational drug extends progression-free survival in a phase 3 trial in patients with platinum-resistant or -refractory ovarian cancer.

Latest News

Fulcrum Therapeutics said on Monday it would stop developing its experimental sickle-cell disease drug ⁠after the U.S. Food and Drug Administration raised cancer-risk...

Incidental splenomegaly detected on imaging may warrant closer evaluation because malignancy and cirrhosis risk increase with splenic size.

Dr Adam Faye discusses best practices for early interventions in ulcerative colitis care.

Although the sensation of defecation urgency in patients with IBS appears in the gut, a recent study suggests that it’s nuanced and related to several regions of the brain.

Experts say an infant’s laughter is an important developmental marker, offering a window into brain development and a child’s emerging social world.

A single fecal microbiota transplantation improved alcohol abstinence and reduced relapse rates in patients with alcohol-associated cirrhosis and alcohol use disorder.

News All Time

Early-Life Stress Raises Gastrointestinal Disease Risk

A study finds adverse early events are linked to gut-brain disruptions in mice and humans.

Shasta County’s Rapid Response to Measles

When measles showed up in Shasta County, health workers moved quickly to trace cases and exposure.

New Vax Policy May Contribute to Rise in Infant Hepatitis B

A recent study projects hundreds more infant hepatitis B infections under new vaccine recommendations.

Cesarean Surgical Complications Linked to Readmission Risk

Patients with surgical complications during cesarean delivery have a higher risk for postpartum readmission within 42 days than those without such complications.

Delaying Methotrexate for Vaccine May Not Impair RA Control

Delaying methotrexate by 1 month to receive the pneumococcal vaccination may not impair disease control or increase joint damage over 1 year in patients with early rheumatoid arthritis.

Light Therapy May Reduce Depression, Boost Sleep Quality

Light therapy is linked to reduced symptoms of depression and improved sleep quality in patients with neuropsychiatric disorders, a new meta-analysis shows.

FDA Approves Cefepime-Zidebactam for Complicated UTIs

The novel IV antibiotic combination works ‘synergistically’ to combat gram-negative pathogens in complicated UTIs and pyelonephritis.

Fact vs. Fallacy: Challenging the Norms of Cancer Care

Dr Bishal Gyawali explores why lowering the bar for drug approvals is a fallacy and why asking for better evidence is a sign of patient advocacy, not an attack on innovation.

The Alcohol-Sugar Double Whammy Coming to Patients Near You

Highly sweetened alcoholic drinks may amplify liver risk by combining concentrated alcohol exposure with metabolic stress.

Exam Rooms Front Line in Fight Against Youth Vaping

Exam rooms are becoming a critical and increasingly complex front line in preventing adolescent nicotine addiction.

Occupational PTSD Typically Affects UK Men More Than Women

A 28-year surveillance study in the UK showed that occupational posttraumatic stress disorder most frequently affected men, with police and military personnel at the highest risk.

CAR-T Therapy Shows Promise in CNS and Extramedullary B-ALL

A retrospective study evaluates the effectiveness of CD19 CAR T-cell therapy in relapsed/refractory B-cell acute lymphoblastic leukemia with extramedullary or CNS disease.

Reassuring Data for Two High-Efficacy MS Meds in Pregnancy

Two longitudinal studies showed no adverse safety signals associated with prenatal exposure to two high-efficacy drugs for MS.

Could AI Bias Make Health Inequalities Worse?

AI bias isn't just a tech problem — it's a potential patient safety issue that every clinician needs to understand.

In Defense of the 2026 Dyslipidemia Guideline

Members of the writing committee for the 2026 ACC/AHA/Multisociety dyslipidemia guidelines respond to a critical column by John Mandrola, MD.

Machine Learning Predicts Recurrence of Barrett's Esophagus

A machine learning model predicted the risk for recurrence of Barrett's esophagus and related neoplasia in certain patients.

Recommended News For You

Prior authorizations draining time, energy from many cancer patients

ctDNA Predicts Relapse in Locally Advanced Cervical Cancer

Mezigdomide Combinations Show Promise in Multiple Myeloma

Research Indicates that First-Line Immunotherapy Is Enough for Elderly NSCLC Patients?

LAIs vs Oral Antipsychotics for Bipolar I Rehospitalization

Three Cycles of Chemo Noninferior to Six for Rare Childhood Eye Cancer

It has been discovered that personalized dosing in the treatment of prostate cancer improves patient outcomes.

Recommended Articles For You

Unraveling the Mysteries of Lymphoma: A Journey into the Unknown 

Exploring the Mystery of Angiokeratomas on Scrotum: Causes, Symptoms and Treatment 

Cancer Rates on the Rise: What Can We Do to Stop It? 

Understanding Dasatinib: A Promising Drug for Cancer Treatment  

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Antibiotic Stewardship: Five Tips to Reduce Resistance

2.

'Chemo brain' cognitive issues linked to poor lymphatic-system drainage

3.

A person's susceptibility to papillary thyroid cancer may be determined by variations in telomere lengthening genes.

4.

When it comes to LBCL relapse in complete remission, ASCT outperforms CAR T-cell therapy.

5.

EMA Backs Breast Cancer SERD After FDA No Vote

1.

Exploring the Latest Treatments for Essential Thrombocythemia

2.

Can AI Become Our Oncologic Ally? A Look at Artificial Intelligence in Cancer Detection and Control

3.

Treating Methemoglobinemia: What You Need to Know Now!

4.

Tertiary Lymphoid Structures in Cancer: Advancing Therapeutic Implications

5.

Understanding Histiocytosis: Symptoms, Causes, and Treatment Options

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part I

2.

INO-VATE: The Long-Term Overall Survival Analysis in Iontuzumab-Treated Patients

3.

Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part II

4.

Benefits of Treatment with CDK4/6 Inhibitors in HR+/HER2- aBC in Clinical Trials and the Real World

5.

Updates on the First Line Management of ALK+ NSCLC

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot